div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentrev-diabetes-61-completa-zinman-b-wanner-c-lachin-jm-et-al-empagliflozin-cardiovascularhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: Rev DIABETES 61 Completa · Zinman B Wanner C Lachin JM et al Empagliflozin cardiovascular outcomes and mortality in type 2 diabetes N EnglJ Med 2015 373:2117—28 Neal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsusreader034viewer20220423115ed8e3cf6714ca7f4768c296html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentrev-diabetes-61-completa-zinman-b-wanner-c-lachin-jm-et-al-empagliflozin-cardiovascularhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: Rev DIABETES 61 Completa · Zinman B Wanner C Lachin JM et al Empagliflozin cardiovascular outcomes and mortality in type 2 diabetes N EnglJ Med 2015 373:2117—28 Neal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsusreader034viewer20220423115ed8e3cf6714ca7f4768c296html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentrev-diabetes-61-completa-zinman-b-wanner-c-lachin-jm-et-al-empagliflozin-cardiovascularhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: Rev DIABETES 61 Completa · Zinman B Wanner C Lachin JM et al Empagliflozin cardiovascular outcomes and mortality in type 2 diabetes N EnglJ Med 2015 373:2117—28 Neal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...